Gregory Scott Duncan
CIK 1831127 · CHIEF EXECUTIVE OFFICER · last filed 2026-03-06
Gregory Scott Duncan is a CHIEF EXECUTIVE OFFICER who has filed 25 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for DWTX, was dated Mar 6, 2026. Across all open-market trades the lifetime net is +$288.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $546.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VIRI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ALPHARETTA, GA 30009
Holdings By Company
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-06 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2026-01-27 | CRMD | Grant (A) | +30,453 | $0 | EDGAR |
| 2025-12-05 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2025-09-18 | CRMD | Exer (M) | +13,333 | $110.9K | EDGAR |
| 2025-07-01 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2025-01-22 | CRMD | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-03-20 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2024-02-28 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-18 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Buy (P) | +25,000 | $31.2K | EDGAR |
| 2023-02-15 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.